Ascendia Pharmaceutical Solutions is a leading Contract Development and Manufacturing Organisation (CDMO) specialising in innovative drug delivery solutions that enhance bioavailability and solubility.

Description:
Based in North Brunswick, New Jersey, Ascendia offers end-to-end pharmaceutical development services, supporting clients from preclinical formulation to commercialisation. With state-of-the-art facilities and proprietary nanotechnology platforms, the company is dedicated to overcoming complex drug development challenges, including poorly soluble drugs, sterile products, and biologics.

Key Products and Services:

• Nanotechnology Platforms: AmorSol®, EmulSol®, LipidSol™, and NanoSol® for advanced formulations.
• Formulation Development: Specialised in solubility and bioavailability enhancement.
• Manufacturing: GMP-compliant sterile and non-sterile manufacturing for various dosage forms.
• Analytical Services: Comprehensive testing and stability studies.
• Clinical Trial Materials: Expertise in scaling for “first-in-human” trials.

With a commitment to making the “Impossible Possible,” Ascendia continues to drive innovation in pharmaceutical development. Its BEST philosophy (Brilliant technology, Excellent service, Superior quality, and Trust) underpins its reputation as a partner of choice in the biopharma industry​